Bristol Myers Squibb Shares Are Trading Lower After the Company's Phase 3 CheckMate -73L Trial Did Not Meet Its Primary Endpoint.
Bristol Myers Squibb Shares Are Trading Lower After the Company's Phase 3 CheckMate -73L Trial Did Not Meet Its Primary Endpoint.
在百時美施貴寶的第三階段CheckMate -73L試驗未達到其主要終點後，該公司的股價走低。
Bristol Myers Squibb Shares Are Trading Lower After the Company's Phase 3 CheckMate -73L Trial Did Not Meet Its Primary Endpoint.
在百時美施貴寶的第三階段CheckMate -73L試驗未達到其主要終點後，該公司的股價走低。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。